🔗 Visit the ClinicalTrials.gov page for NCT02970643
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. | Cancer | 2000 | 7.25 |
| 2 | American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. | J Clin Oncol | 2006 | 4.97 |
| 3 | Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. | N Engl J Med | 2016 | 2.19 |
| 4 | Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. | J Support Oncol | 2011 | 1.62 |
| 5 | Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. | Br J Cancer | 2006 | 1.54 |
| 6 | Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. | J Exp Clin Cancer Res | 2009 | 1.45 |
| 7 | Evidence-based recommendations for cancer nausea and vomiting. | J Clin Oncol | 2008 | 1.28 |
| 8 | Chemotherapy-induced nausea and vomiting. | Cancer J | 2008 | 1.25 |